What Is Thymosin Alpha-1? A Research Overview

Thymosin alpha-1 (Tα1) is a 28-amino-acid thymic peptide studied in immune-signaling and immune-modulation research. It is also produced as a licensed medicine (thymalfasin / Zadaxin) approved in some countries, but the material discussed here is sold strictly for research use only (RUO). It is not that medicine and is not for human or veterinary use, diagnosis, or treatment.

Quick facts

• Class: thymic immune-signaling peptide (28 amino acids)
• Research focus: immune-modulation research (T-cell and dendritic-cell signaling)
• Form: lyophilized powder, ≥99% HPLC purity, third-party tested
• Status: research use only — not for human consumption

What is Thymosin Alpha-1?

Thymosin alpha-1 is a small peptide of 28 amino acids originally isolated from thymosin fraction 5, a preparation derived from the thymus gland. It belongs to a family of thymic peptides involved in coordinating immune-cell development. Because of its compact, well-defined sequence, Tα1 is frequently used as a reference compound in laboratory immunology. The same molecule has been developed pharmaceutically as thymalfasin (marketed as Zadaxin) and is approved in a number of countries for certain clinical indications — a regulatory fact distinct from the RUO research material described on this page.

What does the research show?

Published preclinical and clinical literature has examined Tα1 primarily as an immune modulator. In a multicenter, single-blind, randomized controlled trial in patients with severe sepsis (the ETASS trial), investigators reported a trend toward reduced 28-day mortality and improvement in monocyte HLA-DR expression in the treatment arm [1]. Review literature has summarized its study in viral infectious diseases, including hepatitis B and C [2]. These outcomes are attributed entirely to the published record and describe findings in study populations — they are not claims about this research material or about any reader.

Mechanisms studied in the lab

• T-cell signaling: studied for association with maturation and differentiation of T lymphocytes and a shift toward Th1-type responses.
• Dendritic-cell activation: investigated for priming dendritic cells and modulating antigen presentation [3].
• Toll-like receptor (TLR) pathways: reported to engage TLR signaling (e.g., TLR9), with downstream effects on cytokine production [3].

Research status and safety

The Tα1 offered here is a research-use-only material for in-vitro and laboratory study by qualified researchers. It is not a dietary supplement, drug, or medical product, and is not intended to diagnose, treat, cure, or prevent any disease. Although a thymosin-alpha-1 pharmaceutical exists and is approved in some jurisdictions, that approval does not extend to this research material.

Handling

Thymosin alpha-1 is supplied as a lyophilized powder. Store sealed and protected from light and moisture, and reconstitute only for in-vitro research workflows. See our reconstitution guide for general handling, and browse related items in our research peptide catalog. Product details: Thymosin Alpha-1 — research-grade, ≥99% pure.

FAQ

Is Thymosin alpha-1 the same as Zadaxin? Chemically the peptide is the same 28-amino-acid sequence, but the licensed medicine (thymalfasin / Zadaxin) is a regulated pharmaceutical. The material sold here is research-grade and for laboratory use only — not the medicine and not for human use.

How many amino acids does Thymosin alpha-1 contain? It is a 28-amino-acid peptide, a relatively small and well-characterized molecule for immunology research.

Can I use this product for personal health or dosing? No. This is a research-use-only material. We provide no dosing guidance, and it is not for human or veterinary use of any kind.

References

1. Wu J, et al. The efficacy of thymosin alpha 1 for severe sepsis (ETASS): an RCT. Critical Care. 2013.
2. Tao N, et al. Thymosin alpha1 and Its Role in Viral Infectious Diseases. Molecules. 2023.
3. Romani L, et al. Thymosin alpha1 activates dendritic cell tryptophan catabolism. Blood. 2006.

For research use only. Not for human or veterinary use. The research material is not the approved medicine. Statements have not been evaluated by the FDA.